Comparative susceptibility of Mycoplasma pneumoniae to erythromycin, ciprofloxacin, and lomefloxacin
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (5), 433-435
- https://doi.org/10.1016/0732-8893(89)90115-6
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolonesAntimicrobial Agents and Chemotherapy, 1988
- In-vitro activity of trospectomycin sulphate against Mycoplasma and Ureaplasma species isolated from humansJournal of Antimicrobial Chemotherapy, 1988
- In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolonesAntimicrobial Agents and Chemotherapy, 1988
- In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agentsAntimicrobial Agents and Chemotherapy, 1988
- In vitro and in vivo activity of NY-198, a new difluorinated quinoloneAntimicrobial Agents and Chemotherapy, 1987
- The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroAntimicrobial Agents and Chemotherapy, 1985